Your browser doesn't support javascript.
loading
Short stature as an initial presenting presentation of unicentric Castleman disease in a child: A case report with long-term follow-up and a literature review.
Sonoda, Kaori; Kaneko, Utako; Hiura, Makoto; Kinoshita, Yoshiaki; Umezu, Hajime; Ito, Shuichi; Saitoh, Akihiko; Imai, Chihaya.
Afiliação
  • Sonoda K; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Kaneko U; Department of Pediatrics, Niigata Medical-Care Cooperative, Kido Hospital, Niigata, Japan.
  • Hiura M; Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Kinoshita Y; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Umezu H; Department of Pediatrics, Niigata Medical-Care Cooperative, Kido Hospital, Niigata, Japan.
  • Ito S; Department of Pediatric Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Saitoh A; Division of Pathology, Niigata University Medical and Dental Hospital, Niigata, Japan.
  • Imai C; Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Mod Rheumatol Case Rep ; 7(1): 261-266, 2023 01 03.
Article em En | MEDLINE | ID: mdl-35536586
Short stature is a common clinical condition in paediatric outpatient clinics and is associated with various clinical conditions, ranging from normal variants to severe diseases. Short stature is known to be caused by chronic inflammatory conditions, in which over-produced inflammatory cytokines are reported to be involved in growth suppression. Castleman disease is a rare lymphoproliferative disorder known as a chronic inflammatory disease with overproduction of interleukin 6, which often causes systemic symptoms such as fever, fatigue, weight loss, and night sweats. Here, we report the case of a 10-year-old female diagnosed with unicentric Castleman disease, who presented with short stature as the sole clinical sign but lacked typical systemic symptoms of Castleman disease. An elevated serum C-reactive protein level led us to suspect a chronic inflammatory condition, and we found an intra-abdominal tumour that was histopathologically confirmed as Castleman disease. The tumour removal resulted in a steady catch-up in her height in the six years following the surgery. We also present a brief review of relevant literature on paediatric cases of Castleman disease associated with growth impairment. Clinicians should be aware that chronic inflammatory conditions can cause growth impairment, which may be a key clinical manifestation of such conditions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia do Linfonodo Gigante Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia do Linfonodo Gigante Idioma: En Ano de publicação: 2023 Tipo de documento: Article